Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 2/2000

01-10-2000 | Meeting abstract

Prediction of the underlying histology from the mammogram: mammographic-large section histologic correlation of >1000 open surgical biopsies

Author: L Tabár

Published in: Breast Cancer Research | Special Issue 2/2000

Login to get access

Excerpt

The radiologist greatly enhances her or his skills by regular review of the preoperative mammograms once the histologic diagnosis became available. …
Metadata
Title
Prediction of the underlying histology from the mammogram: mammographic-large section histologic correlation of >1000 open surgical biopsies
Author
L Tabár
Publication date
01-10-2000
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2000
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr233

Other articles of this Special Issue 2/2000

Breast Cancer Research 2/2000 Go to the issue

Meeting abstract

Galactoductography

Meeting abstract

Audit rules OK! The benefits of an internal quality audit programme in the breast screening service

Meeting abstract

Assessing an individual's film reading ability

Meeting abstract

An evaluation of the relationship between compressed breast thickness and glandular dose, within the breast screening service

Meeting abstract

Galactocele in a postmenopausal woman: a case report

Meeting abstract

Who does what? Comments from radiographers
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits